More on PFE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders
- Dividends

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

PFE Income Statement

Click line-items for a historical chart and %
Revenues 12.77B
Costs and expenses:
Cost of sales
Selling, informational and administrative expenses 3.52B
Research and development expenses 1.76B
Amortization of intangible assets
Acquisition-related in-process research and development charges
Restructuring charges and certain acquisition-related costs 81M
Other deductions--net -53M
Income from continuing operations before provision for taxes on income 4B
Provision for taxes on income 1.08B
Income from continuing operations 2.92B
Discontinued operations:
Income from operations--net of tax -2M
Gain on sale of discontinued operations--net of tax 2M
Discontinued operations--net of tax 0
Net income before allocation to noncontrolling interests 2.92B
Less: Net income attributable to noncontrolling interests 9M
Net income attributable to Pfizer Inc. 2.91B
Earnings per share--basic:
Income from continuing operations attributable to Pfizer Inc. common shareholders 0.46
Discontinued operations--net of tax (in dollars per share) 0
Net income attributable to Pfizer Inc. common shareholders (in dollars per share) 0.46
Earnings per share--diluted:
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share) 0.45
Discontinued operations--net of tax (in dollars per share) 0
Net income attributable to Pfizer Inc. common shareholders (in dollars per share) 0.45
Weighted-average shares used to calculate earnings per common share:
Basic (in shares) 6.37B
Diluted (in shares) 6.44B
Cash dividends paid per common share (in dollars per share) 0.26